Goldman upgrades Five Below, sees 18% rally ahead as vaccine rolls out - CNBC

bolaboladulu.blogspot.com

Joel Anderson, CEO, Five Below 

Scott Mlyn | CNBC

(This story is for CNBC Pro subscribers only.)

Goldman Sachs is bullish on Five Below as a Covid-19 vaccine should be a catalyst for cyclical outperformance.

The Wall Street firm upgraded shares of Five Below to buy from neutral with a $194 per share price target, implying 18% upside from the discount retailers current levels.

Let's block ads! (Why?)

"five" - Google News
December 10, 2020 at 08:08PM
https://ift.tt/3gwDI5Q

Goldman upgrades Five Below, sees 18% rally ahead as vaccine rolls out - CNBC
"five" - Google News
https://ift.tt/2YnPDf8
https://ift.tt/2SxXq6o